Sulphadimethoxypyrimidine
Sulphadimethoxypyrimidine is an orally active, long-acting sulfonamide antibacterial agent, which is often administered in combination with Sulfamethazine (HY-B0035). Administration of Sulphadimethoxypyrimidine during pregnancy causes incisor malformations in rat offspring. Sulphadimethoxypyrimidine can be used in the research of bacterial infections.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 155-91-9
- 分子式: C12H14N4O4S
- 分子量:310.33
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体内実験
Sulphadimethoxypyrimidine (100 mg/kg; p.o.; single dose) administered orally at 100 mg/kg is rapidly excreted in New Zealand white rabbits, with no detectable N1-glucuronide formed and unchanged drug accounting for 36% of the 24-hour urinary excretion[1].
Sulphadimethoxypyrimidine (100 mg/kg; p.o.; single dose) administered orally at 100 mg/kg is slowly excreted in Wistar albino rats, with unchanged drug accounting for 58% of the 24-hour urinary excretion and only 7% consisting of the N1-glucuronide metabolite[1].
Sulphadimethoxypyrimidine (100 mg/kg; i.p.; single dose) administered intraperitoneally at 100 mg/kg shows 24-hour urinary excretion of 22% in Wistar albino rats, which is more than three times the excretion seen after oral administration[1].
Sulphadimethoxypyrimidine (100 mg/kg; i.p.; single dose) administered intraperitoneally at 100 mg/kg is excreted in bile of cannulated Wistar albino rats, with 19.0% of the dose recovered in 24 hours and the N4-glucuronide accounting for the majority of biliary metabolites[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 155-91-9
-
分子量 310.33
-
分子式 C12H14N4O4S
-
SMILES
O=S(NC1=NC(OC)=CC(OC)=N1)(C2=CC=C(C=C2)N)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Sulphadimethoxypyrimidine
- 155-91-9
- Bacterial
- bacterial infections
- rabbits
- N1-glucuronide
- N
- N4-glucuronide
- incisor malformation
- N4-sulphate
- rhesus monkeys
- rats
- humans
- Inhibitor
- inhibitor
- inhibit